Page 15 - TROMBOCITOPENIA INMUNE PRIMARIA (PTI)

Bibliografía recomendada
Definición de trombocitopenia inmune y pruebas diagnósticas
Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009 Jun 25;113(26):6511-21. [Pubmed]
Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter. 2015 Aug;20(4):239-51. [Pubmed]
Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2001 Dec;115(4):1002-3. [Pubmed]
Lozano ML, Sanz MA, Vicente V, et al. Sociedad Española de Hematología y Hemoterapia- Grupo Español de Trombocitopenia Inmune. Directrices de diagnóstico, tratamiento
y seguimiento de la PTI. Recomendaciones del Grupo de Trabajo de la SEHH y GEPTI. [Enlace]
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829-66. [Pubmed]
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780-817. [Pubmed]
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14;115(2):168-86. [Pubmed]
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12;113(11):2386-93. [Pubmed]
Vrbensky JR, Moore JE, Arnold DM, Smith JW, Kelton JG, Nazy I. The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test. J Thromb Haemost. 2019 May;17(5):787-94. [Pubmed]
Ye QD, Jiang H, Liao XL, Chen K, Li SS. Identification and Validation of Gene Expression Pattern and Signature in Patients with Immune Thrombocytopenia. SLAS Discov. 2017 Feb;22(2):187-195. [Pubmed]
Tratamiento de las trombocitopenias inmunes
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829-66. [Pubmed]
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780-817. [Pubmed]
Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood. 2013 Jan 17;121(3):537-45. [Pubmed]
Agonistas del receptor de la trombopoyetina
Bussel J, Kuter D, Pullarkat V, Lyons R, Guo M, Nichol J. Safety and efficacy of longterm treatment with romiplostim in thrombocytopenic patients with chronic PTI. Blood 2009; 113(10): 2161-171. [Pubmed]
González-Porras JR, Godeau B, Carpenedo M. Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia. Ther Adv Hematol. 2019 May 9;10:2040620719837906. [Pubmed]
Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, et al. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol. 2013 May;161(3):411-23. [Pubmed]
Esplenectomía
Radkowiak D, Zychowicz A, Lasek A, Wysocki M, Major P, Pędziwiatr M, et al. 20 years’ experience with laparoscopic splenectomy. Single center outcomes of a cohort study of 500 cases. Int J Surg. 2018 Apr;52:285-92. [Pubmed]